Cerity Partners LLC Innoviva, Inc. Transaction History

Cerity Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$11.06 - $12.87 $145,604 - $169,433	-13,165 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$9.33 - $12.48 $122,829 - $164,299	13,165 New	13,165 $163,000
Q1 2019 May 14, 2019	SELL	$13.69 - $20.06 $211,428 - $309,806	-15,444 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$13.96 - $18.26 $5,276 - $6,902	-378 Reduced 2.39%	15,444 $269,000
Q3 2018 Nov 15, 2018	BUY	$13.63 - $15.7 $31,730 - $36,549	2,328 Added 17.25%	15,822 $241,000
Q2 2018 Aug 15, 2018	BUY	$13.44 - $17.59 $181,359 - $237,359	13,494 New	13,494 $186,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Cerity Partners LLC with notifications on news.